These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18808157)

  • 1. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
    Guttmann D; Poage G; Johnston T; Zhitkovich A
    Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
    Quievryn G; Messer J; Zhitkovich A
    Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
    Zhitkovich A; Song Y; Quievryn G; Voitkun V
    Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
    Zhitkovich A; Quievryn G; Messer J; Motylevich Z
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.
    Quievryn G; Goulart M; Messer J; Zhitkovich A
    Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mutagenic DNA damage by chromium (VI) and glutathione.
    Liu S; Dixon K
    Environ Mol Mutagen; 1996; 28(2):71-9. PubMed ID: 8844987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of Cr(VI) by ascorbate but not glutathione is a low oxidant-generating process.
    Wong V; Armknecht S; Zhitkovich A
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):192-6. PubMed ID: 22572042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.
    Zhitkovich A; Voitkun V; Costa M
    Carcinogenesis; 1995 Apr; 16(4):907-13. PubMed ID: 7728973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest.
    O'Brien T; Xu J; Patierno SR
    Mol Cell Biochem; 2001 Jun; 222(1-2):173-82. PubMed ID: 11678599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
    Zhitkovich A; Shrager S; Messer J
    Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells.
    Voitkun V; Zhitkovich A; Costa M
    Nucleic Acids Res; 1998 Apr; 26(8):2024-30. PubMed ID: 9518499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of DNA single-strand breaks during reduction of chromate by glutathione in vitro and in cells.
    Messer J; Reynolds M; Stoddard L; Zhitkovich A
    Free Radic Biol Med; 2006 Jun; 40(11):1981-92. PubMed ID: 16716899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Cr intermediates and reactive oxygen species with fluorescent probes during chromate reduction.
    DeLoughery Z; Luczak MW; Zhitkovich A
    Chem Res Toxicol; 2014 May; 27(5):843-51. PubMed ID: 24646070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione.
    Kortenkamp A; Casadevall M; Faux SP; Jenner A; Shayer RO; Woodbridge N; O'Brien P
    Arch Biochem Biophys; 1996 May; 329(2):199-207. PubMed ID: 8638952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
    Morse JL; Luczak MW; Zhitkovich A
    Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair.
    Reynolds M; Stoddard L; Bespalov I; Zhitkovich A
    Nucleic Acids Res; 2007; 35(2):465-76. PubMed ID: 17169990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate.
    Wiegand HJ; Ottenwälder H; Bolt HM
    Toxicology; 1984 Dec; 33(3-4):341-8. PubMed ID: 6515663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.